Skip to main content

Table 1 Proportion of subjects with HAI ≥:1:40 at baseline (S1), 28 days post-vaccination (S2), and after influenza season (S3) and with seroconversion at S2, by influenza strain

From: Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults

Seroprotection

H1N1

H3N2

B

% (N)

% (N)

% (N)

Baseline (S1)

9% (44)

48% (235)

43% (214)

28 days post-vaccination (S2)

26% (126)

82% (407)

72% (354)

After influenza season (S3)

9% (46)

59% (289)

53% (263)

Seroconversion

   

28 days post-vaccination (S2)

12% (60)

45% (222)

28% (138)